Fig. 8: Luteolin inhibited NSCLC growth in vivo.
From: Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
a Images of resected xenograft samples. b Average tumor volumes. c Average tumor weights. d The body weights of mice. e The viscera indexes of mice main organs. f RT-qPCR assay for the expressions of AIM2, caspase-1, and IL-1β in tumor tissues. g, h Western blot analysis for the expressions of AIM2, pro-caspase-1, caspase-1 p10, pro-IL-1β, and IL-1β in tumor tissues. i, j Immunohistochemical staining of PCNA and AIM2 in tumor tissues (scale bar = 100 μm). *P < 0.05, **P < 0.01, ***P < 0.001 vs control
